Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Ultrasound histogram assessment of parotid gland injury following head-and-neck radiotherapy: a feasibility study.

Yang X, Tridandapani S, Beitler JJ, Yu DS, Yoshida EJ, Curran WJ, Liu T.

Ultrasound Med Biol. 2012 Sep;38(9):1514-21. doi: 10.1016/j.ultrasmedbio.2012.05.005.

2.

Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.

Yang X, Tridandapani S, Beitler JJ, Yu DS, Chen Z, Kim S, Bruner DW, Curran WJ, Liu T.

Acad Radiol. 2014 Oct;21(10):1304-13. doi: 10.1016/j.acra.2014.05.017.

3.

Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity.

Yang X, Tridandapani S, Beitler JJ, Yu DS, Yoshida EJ, Curran WJ, Liu T.

Med Phys. 2012 Sep;39(9):5732-9. doi: 10.1118/1.4747526.

4.

Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: a feasibility study of late toxicity.

Yang X, Tridandapani S, Beitler JJ, Yu DS, Wu N, Wang Y, Bruner DW, Curran WJ, Liu T.

Med Phys. 2014 Feb;41(2):022903. doi: 10.1118/1.4862507.

5.

Metabolic imaging biomarkers of postradiotherapy xerostomia.

Cannon B, Schwartz DL, Dong L.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1609-16. doi: 10.1016/j.ijrobp.2011.10.074.

6.

Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.

Anand AK, Jain J, Negi PS, Chaudhoory AR, Sinha SN, Choudhury PS, Kumar R, Munjal RK.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):497-504.

PMID:
16909975
7.

Investigations on parotid gland recovery after IMRT in head and neck tumor patients.

Stock M, Dörr W, Stromberger C, Mock U, Koizar S, Pötter R, Georg D.

Strahlenther Onkol. 2010 Dec;186(12):665-71. doi: 10.1007/s00066-010-2157-7.

PMID:
21136030
8.

Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.

Eisbruch A, Ship JA, Martel MK, Ten Haken RK, Marsh LH, Wolf GT, Esclamado RM, Bradford CR, Terrell JE, Gebarski SS, Lichter AS.

Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):469-80.

PMID:
8892473
9.

Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.

Amosson CM, Teh BS, Van TJ, Uy N, Huang E, Mai WY, Frolov A, Woo SY, Chiu JK, Carpenter LS, Lu HH, Grant WH 3rd, Butler EB.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):136-44.

PMID:
12694832
10.

Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.

Chen WC, Lai CH, Lee TF, Hung CH, Liu KC, Tsai MF, Wang WH, Chen H, Fang FM, Chen MF.

Oral Oncol. 2013 Jan;49(1):42-8. doi: 10.1016/j.oraloncology.2012.07.004.

PMID:
22854066
11.

Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.

Belli ML, Scalco E, Sanguineti G, Fiorino C, Broggi S, Dinapoli N, Ricchetti F, Valentini V, Rizzo G, Cattaneo GM.

Strahlenther Onkol. 2014 Oct;190(11):1001-7. doi: 10.1007/s00066-014-0669-2.

PMID:
24756139
12.

Comparison of sonographic appearance of normal and postradiotherapy parotid glands: a preliminary study.

Ying M, Wu VW, Kwong DL.

Ultrasound Med Biol. 2007 Aug;33(8):1244-50.

PMID:
17466447
13.

Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.

Münter MW, Karger CP, Hoffner SG, Hof H, Thilmann C, Rudat V, Nill S, Wannenmacher M, Debus J.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):175-84.

PMID:
14697436
14.

Radiation-induced damage to microstructure of parotid gland: evaluation using high-resolution magnetic resonance imaging.

Kan T, Kodani K, Michimoto K, Fujii S, Ogawa T.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1030-8. doi: 10.1016/j.ijrobp.2009.06.010.

PMID:
19879064
15.

The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.

Rudat V, Münter M, Rades D, Grötz KA, Bajrovic A, Haberkorn U, Brenner W, Debus J.

Radiother Oncol. 2008 Oct;89(1):71-80. doi: 10.1016/j.radonc.2008.07.016.

PMID:
18707782
16.

Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer.

Voordeckers M, Everaert H, Tournel K, Verellen D, Baron I, Van Esch G, Vanhove C, Storme G.

Strahlenther Onkol. 2008 Aug;184(8):400-5.

PMID:
18956516
17.

Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.

Bussels B, Maes A, Flamen P, Lambin P, Erven K, Hermans R, Nuyts S, Weltens C, Cecere S, Lesaffre E, Van den Bogaert W.

Radiother Oncol. 2004 Dec;73(3):297-306.

PMID:
15588874
18.

Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumour.

Kaneko M, Shirato H, Nishioka T, Ohmori K, Takinami S, Arimoto T, Kagei K, Miyasaka K, Nakamura M.

Oral Oncol. 1998 Mar;34(2):140-6.

PMID:
9682778
19.

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, Low DA.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):907-16.

PMID:
11240231
20.

Supplemental Content

Support Center